Homepage
-
Feature
09 May, 2024|iSpeak BlogThe following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas
30 April, 2024|iSpeak BlogThe integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track
29 April, 2024|iSpeak BlogThe pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between -
Calendar Of Events
-
Videos
|Video2023-2025 We are pleased to share the 2023–2025 ISPE Strategic Plan video, which reflects an ongoing commitment to our mission and vision and outlines our priorities for the next three years. Hear from ISPE International...
|VideoThis European Annual Conference draws pharmaceutical and biopharmaceutical professionals at all levels of the industry - from students and emerging leaders to the most senior executives in drug manufacturing, supply...
|VideoISPE unveiled the prestigious 2023 Facility of the Year Award (FOYA) Overall Winner recipient during the FOYA Celebratory Reception and Banquet at the 2023 ISPE Annual Meeting & Expo. The event showcased the overall...
Guidance Documents
-
Guide: 503A Compounding
-
Guide: ATMPs - rAAV Comparability & Lifecycle Mgmt
Guide: ATMPs - rAAV Comparability & Lifecycle Mgmt
PublishedPublished: January 2024
Pages: 98 -
Guide: ATMPs - Allogeneic Cell Therapy
Guide: ATMPs - Allogeneic Cell Therapy
PublishedPublished: January 2024
Pages: 144 -
Baseline Guide Vol 8: Pharma 4.0 1st Edition
Baseline Guide Vol 8: Pharma 4.0 1st Edition
PublishedPublished: December 2023
Pages: 270
Not a Member Yet?
Whether networking at events or collaborating through our Communities of Practice, the value of an ISPE membership is in the connections made between pharmaceutical industry professionals and Regulators to collaborate on solutions to common goals and challenges.
